SLS
Sellas Life Sciences Group Inc
11.60$
-3.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,197.09 | -2,408.00 | -135.31 | -234.77 | -116.32 | -6.90 | -1.31 | -1.68 | -1.23 | -1.13 | -0.58 | -0.26 | |
| 24.82 | 17.75 | 0.43 | 0.00 | 14.37 | 0.66 | 0.04 | 0.37 | 0.02 | – | – | – | |
| 150.43 | 96.55 | 6.82 | 67.70 | 1.51 | 0.22 | 0.07 | 0.07 | 0.09 | 0.05 | 0.03 | 0.02 | |
| 156.01 | -353.10 | -27.65 | 137.63 | 28.86 | 1.29 | 0.09 | 0.15 | 0.61 | – | – | – | |
| 111.33 | 993.65 | -75.06 | 129.57 | -38.26 | -0.43 | 0.70 | -0.49 | 0.29 | 0.12 | -0.11 | -0.04 | |
| 154.37 | 7.65 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.23 | 0.20 | 0.00 | 0.00 | |
| -154.37 | 519.75 | -3.18 | 38.71 | – | -1.76 | -0.56 | -0.29 | -0.23 | -0.20 | – | – | |
| 0.00 | 24.35 | 1.47 | 14.42 | 1.86 | 0.00 | – | – | – | – | – | – | |
| 719.42 | 2,372.35 | 102.51 | 10.11 | 119.33 | 7.65 | 4.78 | – | – | 0.00 | – | – | |
| -49.31 | -195.55 | 53.69 | -10.11 | -29.06 | – | – | – | – | – | – | – | |
| 677.45 | 2,192.25 | 103.40 | 118.23 | 88.41 | 7.65 | 4.82 | 0.78 | 1.24 | 0.80 | 0.76 | 0.79 | |
| -674.01 | 304.00 | -35.09 | -77.83 | -27.91 | 0.75 | 3.51 | -0.90 | -0.22 | -0.53 | 0.19 | 0.53 | |
| -1,351.46 | -2,415.65 | -135.32 | -234.77 | -116.32 | -6.90 | -1.31 | -1.68 | -1.46 | -1.33 | -0.58 | -0.26 |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.